Alabama
Birmingham; Alliance Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Dothan; HARMONEX
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Haleyville; Winston Technology Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Hoover; Clinical Research Consultants
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Huntsville; Genesis Clinical Research Corporation
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Northport; Neurology Clinic PC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Tuscaloosa; Neurology Consultants of Tuscaloosa
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Alaska
Little Rock; Clinical Study Centers LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Arizona
Chandler; Radiant Research, Phoenix Southeast
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Peoria; Pivotal Research Centers, LLC
Tingling - Burning - Shooting
pain in your feet due to Diabetic Neuropathy? (Peoria, AZ)
Phoenix; Lovelace Scientific Resources, Inc.
Do you have painful diabetic neuropathy?
Phoenix; Arizona Research Center, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Tucson; Advanced Clinical Therapeutics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Tucson; Northwest NeuroSpecialists, PLLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Tucson; Genova Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Tucson; Harmony Clinical, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Arkansas
Hot Springs; Central Arkansas Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Jonesboro; NEA Clinic - Endocrinology
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Little Rock; Clinical Trials, Inc
Painful Diabetic Peripheral Neuropathy
Little Rock; Clinical Trials, Inc.
Painful Diabetic Peripheral Neuropathy
California
Beverly Hills; Lovelace Scientific Resources, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Fresno; Valley Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Garden Grove; Harmony Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Huntington Beach; Diabetes/Lipid Management and Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Irvine; NervePro Medical Corporation
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
La Jolla; Center for Pain and Palliative Medicine
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
La Jolla; Coordinated Clinical Research (La Jolla, CA)
If you have Type I or Type 2 Diabetes and experience pain, numbness, pins and needles or tingling in your fingers or feet you may qualify to participate in research
La Jolla; Coordinated Clinical Research (La Jolla, CA)
Do you have Diabetes? Are you experiencing pain, tingling, burning, or numbness in your hands or feet?
La Mesa; Diabetes and Endocrine Associates
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
La Mesa; Diabetes and Endocrine Associates
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Los Angeles; Doheny Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Los Angeles; Healthcare Partners Medical Group
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Los Banos; K D Medical Group, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Rancho Mirage; Southwest Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
San Francisco; Bay Area Foot Care
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Santa Monica; Neurological Research Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Santa Monica; Neurological Research Institute
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Santa Monica; Coastal Biomedical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Spring Valley; Encompass Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Walnut Creek; Diablo Clinical Research
Do you suffer from diabetic neuropathy?
Walnut Creek; Diablo Clinical Research
Pain in your feet?
Walnut Creek; Diablo Clinical Research
Diabetic and suffering from symptoms of Neuropathy?
Walnut Creek; Diablo Clinical Research
Do you have Painful Diabetic Neuropathy?
Walnut Creek; Diablo Clinical Research
Attention Diabetics: Pain Relief Study.
Colorado
Boulder; Alpine Clinical Research Centre
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Boulder; Alpine Clinical Research Center
Evaluation of a New Medication for Treatment of Painful Diabetic Neuropathy
Connecticut
Pawcatuck; CNS Research of CT, Inc.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupTrial to Evaluate the Efficacy and Safety of E2007 in Patients with Painful Diabetic Neuropathy
Waterbury; Phoenix Internal Medicine Associates, LLC
Painful Distal Diabetic Neuropathy
Delaware
Wilmington; Community Health Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Florida
Bradenton; Bradenton Neurology, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Bradenton; Bradenton Research
Do you suffer from painful diabetic neuropathy?
Clearwater; Clinical Research of West Florida, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Clearwater; Clinical Research of West Florida, Inc.
Together, we can fight DIABETIC NEUROPATHY PAIN. If your a diabetic who's experiencing tingling or burning foor pain, you can participate in a research study to evaluate an investigational pain medication that is unique in how it effects pain.
Deland; University Clinical Research-Deland, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Delray Beach; Brain Matters Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Fort Myers; Clinical Physiology Associates, Inc.- Clinical Study Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Ft. Lauderdale; Neurologic Consultants PA
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Ft. Myers; Clinical Study Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Hallandale Beach; MD Clinical
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Hollywood; South Florida Clinical Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Hollywood; Sunrise Clinical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Miami; Gables Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Miami; Neuroscience Consultants
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Ocala; Renstar Medical Research
Diabetic Peripheral Neuropathy
Ocala; Renstar Medical Research
Painful Diabetic Neuropathy Research
Ormond Beach; Peninsula Research, Inc.
High Blood Pressure
Ormond Beach; Peninsula Research, Inc.
Arthritis Pain needing strong pain medications
Ormond Beach; Peninsula Research, Inc.
Numbness or Pain in feet due to Diabetes/Neuropathy
Palm Beach Gardens; Palm Beach Neurological Center
Diabetic Neuropathy
Palm Beach Gardens; Palm Beach Neurological Center
The purpose of this research study is to evaluate the safety and effectiveness of an investigational medication versus placebo (no active medication) to treat Diabetic Peripheral Neuropathy.
Pembroke Pines; University Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
St. Petersburg; Comprehensive Neuroscience, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
St. Petersburg; Comprehensive NeuroScience, Inc. St. Petersburg
St. Petersburg, FL - Diabetic Neuropathy
Sunrise; Neurology Clinical Research Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Sunrise; Neurology Clinical Research Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Sunrise; Neurology Clinical Research Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Tampa; Clinical Research of West FL, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Tampa; Stedman Clinical Trials
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Tampa; Clinical Research of West Florida
Together We Can Fight Diabetic Neuropathy Pain
Georgia
Dawsonville; North Georgia Premier Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Marietta; Drug Studies America
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Marietta; Drug Studies America
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Illinois
Chicago; Pain and Rehabilitation Clinic of Chicago
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Indiana
Elkhart; Elkhart Clinic, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Evansville; Medisphere Medical Research Center, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Evansville; Research Solutions, LLC.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Valparaiso; Northwest Indiana Center for Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Kentucky
Louisville; L-MARC Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Madisonville; Commonwealth Biomedical Research LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Maryland
Owings Mills; Crossroads Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Massachusetts
Bellingham; CNS Research of MA, Inc.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupTrial to Evaluate the Efficacy and Safety of E2007 in Patients with Painful Diabetic Neuropathy
Boston; Brigham and Women's Hospital (BWH)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupTrial to Evaluate the Efficacy and Safety of E2007 in Patients with PainfulDiabetic Neuropathy
Brockton; Beacon Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Michigan
Ann Arbor; Michigan Head-Pain & Neurological Institute
Diabetic Neuropathy Pain
Ann Arbor; Michigan Head Pain & Neurological Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Missouri
St. Louis; Medex Healthcare Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
St. Louis; Mercy Health Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
St. Louis; Radiant Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Montana
Great Falls; Advanced Neurology Specialists
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Nebraska
Omaha; Creighton Diabetes Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Nevada
Las Vegas; University of Wisconsin Hospital and Clinics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
New Mexico
Albuquerque; Lovelace Scientific Resources, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Albuquerque; Lovelace Scientific Resources, Inc.
Do you have painful Diabetic Neuropathy?
New York
Albany; Upstate Clinical Research, LLC
If you have diabetes and have numbness, tingling, pain or loss of feeling in your feet, legs, hands or arms, you may be eligible to participate in a research study of an investigational medication.
Albany; Neurological Associates of Albany
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Albany; Upstate Clincal Research, LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Buffalo; Diabetes-Endocrinology Center of Western New York
Do you have diabetes, and prickling, tingling, numbness, or pain in your hands and feet?
Buffalo; Kaledia Health / Diabetes-Endocrinology Center of Western New York
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Flushing ; Diabetes Care and Information Center of NY
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
New York; Biomedical Research Alliance of New York
Pain relief in patients with peripheral neuropathic pain conditions
New York; Analgesic Development Ltd.
Do you have painful diabetic neuropathy (pain in your lower legs or feet)?
New York; Columbia University Medical Center
Vascular Endothelial Growth Factor for Treatment of Diabetic Neuropathy
Valley Stream; North American Partners in Pain Management
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Williamsville; Upstate Clinical Research Associates
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
North Carolina
Greenville; ECU Diabetes Research Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Ohio
Cincinnati; Community Research
Diabetic Neuropathy
Cincinnati; Hightop Medical Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Cincinnati; Radiant Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Cincinnati; Radiant Research - Cincinnati
Diabetic Neuropathy Research Study
Kettering; Wells Institute for Health Awareness
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Kettering; Wells Institute for Health Awareness
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Mogadore; Radiant Research - Akron
Diabetic Neuropathy Clinical Research
Mogadore; Radiant Research
Do You Feel Numbness, Tingling, Burning, and Pain in Your Feet From Diabetes?
Toledo; Neurology & Neuroscience Center of Ohio
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful Diabetic neuropathy for 6 months to 10 years.
Oklahoma
Oklahoma City; Health Research Institute
Diabetic Peripheral Neuropathy (DPN)
Tulsa; AHS Oklahoma Physicians Group
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Tulsa; Neurological Center of Oklahoma, PLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Oregon
Medford; Medford Medical Clinic
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Portland; Covance CRU, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Pennsylvania
Altoona; Allegheny Pain Management
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Downingtown; Brandywine Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Duncansville; Altoona Center for Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Morrisville; Bucks County Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Rhode Island
Providence; CNS Research of RI, Inc.
Phase II - Diabetic Neuropathy - Fidaristat from Sankyo Pharma, Inc.
Providence; CNS Research of MA, Inc.
Phase II - Diabetic Neuropathy - Fidaristat from Sankyo Pharma, Inc.
Providence; CNS Research of CT, Inc.
Phase II - Diabetic Neuropathy - Fidaristat from Sankyo Pharma, Inc.
Providence; CNS Research of RI, Inc.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupTrial to Evaluate the Efficacy and Safety of E2007 in Patients with Painful Diabetic Neuropathy
Providence; CNS Research of RI, Inc.
Phase III - Painful Diabetic Peripheral Neuropathy - Topamax from Johnson & Johnson, Inc.
Providence; CNS Research of MA, Inc.
Phase III - Painful Diabetic Peripheral Neuropathy - Topamax from Johnson & Johnson, Inc.
Providence; CNS Research of CT, Inc.
Phase III - Painful Diabetic Peripheral Neuropathy - Topamax from Johnson & Johnson, Inc.
Warwick; Omega Medical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
South Carolina
Anderson; Hartwell Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Greer; Radiant Research, Greer
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Greer; Radiant Research - Greer
Diabetic Neuropathy Research Study.
Mount Pleasant; Coastal Carolina Research Center
Are you diabetic? Volunteers needed for diabetic peripheral neuropathy or DPN study.
Tennessee
Bristol; Tricities Medical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Nashville; Dial Research Associates, Inc.
Together we can fight diabetic neuropathy pain.
Tullahoma; Progress Clinical Trials
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Texas
Beaumont; DiscoveResearch, INC.
You may qualify for a clinical research study if you have Diabetic Peripheral Neuropathy (nerve pain)
Carrollton; MedicalEdge Healthcare Group, PA
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Dallas; Radiant Research - Dallas, North
Diabetic Neuropathy Research Study
Dallas; Radiant Research Dallas-North
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Dallas; Radiant Research - Dallas North
Diabetic Neuropathy Research Study
Houston; Nerve and Muscle Center of Texas
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Lake Jackson; R/D Clinical Research, Inc.
Diabetic Pain Research Study
Lake Jackson; R/D Clinical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
San Antonio; Diabetes & Glandular Disease Research Associates Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
San Antonio; Clinical Trials of Texas, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
San Antonio; InVisions Consultants, LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Virginia
Virginia Beach; Advanced Pain Management & Rehabilitation
Hilltop Medical Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Washington
Renton; Rainier Clinical Research Center Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)
Renton; Rainier Clinical Research Center, Inc.
Diabetic Neuropathy
Spokane; Rockwood Clinic P.S. Research Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Tacoma; Cedar Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
Wisconsin
Madison; University of Wisconsin Hospital and Clinics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.
